DISCLAIMER: The Tear Film Imager (TFI) is currently NOT indicated as a stand-alone diagnostic modality for any specific ocular or systemic disease
The cornerstone of AdOM, Advanced Optical Technologies Ltd focuses on two areas: state-of-the-art optical imaging capabilities and leading ophthalmology clinical and research skills. AdOM utilizes its team’s vast knowledge in thin-film optical imaging technologies to master the spectral imaging domain for the service of clinical ophthalmology. The company is currently focused on the commercialization of our state-of-the-art Tear Film Imaging (TFI) device which measures clinically relevant parameters of the tear film dynamics.
More than 30 different patent applications have been filed for the AdOM technology, of which twenty-one (21) were granted both in Israel, the US, and the EU. This cutting-edge technology has been published by several peer-reviewed scientific journals.
CEO & President AdOM Americas Corp.
Business Development & Marketing Manager
Head of R&D
Professor of Ophthalmology,
Eastern Virginia Medical School
Cornea Specialist, Sheba Hospital
Director of Cornea Fellowship Columbia University, NY
Cornea Specialist, Bascom Palmer Eye Institute, FL
Chairman Dept. of Ophthalmology
Moran Eye Center
Director of Beijing Tongren Eye Center